Lv1
16 积分 2025-03-13 加入
Leridistim, a Chimeric Dual G‐CSF and IL‐3 Receptor Agonist, Enhances Multilineage Hematopoietic Recovery in a Nonhuman Primate Model of Radiation‐Induced Myelosuppression: Effect of Schedule, Dose, and Route of Administration
15小时前
待确认
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells
1天前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
4天前
已完结
Implications of IL-21 in solid tumor therapy
4天前
已完结
From bench to bedside: the past, present and future of IL-21 immunotherapy
4天前
已完结
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions
5天前
已完结
Development of α‐Gal–Antibody Conjugates to Increase Immune Response by Recruiting Natural Antibodies
7天前
已完结
Synergistic anticancer effects of interleukin-21 combined with therapeutic peptides in multiple cancer cells
12天前
已完结
Pyroptosis-mediator GSDMD promotes Parkinson’s disease pathology via microglial activation and dopaminergic neuronal death
17天前
已完结
In situ delivery of Gasdermin E mRNA promotes antitumor immunity via creatine-elicited type Ⅰ interferon signaling in monocytes
17天前
已完结
皖公网安备34019202002308
